Literature DB >> 27489472

Difficulties in the treatment of an Infant with Hemophilia B.

Serdar Özkasap1, Selim Dereci2, Gül Nihal Özdemir3, Bülent Zülfikar3.   

Abstract

Entities:  

Year:  2016        PMID： 27489472      PMCID： PMC4959742          DOI： 10.5152/TurkPediatriArs.2016.3626

Source DB:  PubMed          Journal:  Turk Pediatri Ars


× No keyword cloud information.
  8 in total

1.  Bleeding reduction during secondary prophylaxis with bypassing agents in inhibitor patients.

Authors:  Bruce M Ewenstein; Wing-Yen Wong; Axel Schoppmann
Journal:  Thromb Res       Date:  2010-09-01       Impact factor: 3.944

2.  Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B mice.

Authors:  Dheeraj Verma; Babak Moghimi; Paul A LoDuca; Harminder D Singh; Brad E Hoffman; Roland W Herzog; Henry Daniell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

3.  Factor IX inhibitors and anaphylaxis in hemophilia B.

Authors:  I Warrier; B M Ewenstein; M A Koerper; A Shapiro; N Key; D DiMichele; R T Miller; J Pasi; G E Rivard; S S Sommer; J Katz; F Bergmann; R Ljung; P Petrini; J M Lusher
Journal:  J Pediatr Hematol Oncol       Date:  1997 Jan-Feb       Impact factor: 1.289

Review 4.  Inhibitor treatment in haemophilias A and B: inhibitor diagnosis.

Authors:  D M DiMichele
Journal:  Haemophilia       Date:  2006-12       Impact factor: 4.287

5.  Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis.

Authors:  A Iorio; E Oliovecchio; M Morfini; P M Mannucci
Journal:  Haemophilia       Date:  2008-03-18       Impact factor: 4.287

6.  Occurrence of hemophilia in the United States. The Hemophilia Surveillance System Project Investigators.

Authors:  J M Soucie; B Evatt; D Jackson
Journal:  Am J Hematol       Date:  1998-12       Impact factor: 10.047

Review 7.  Inhibitor development in haemophilia B: an orphan disease in need of attention.

Authors:  Donna DiMichele
Journal:  Br J Haematol       Date:  2007-08       Impact factor: 6.998

8.  Development of anaphylactic shock in haemophilia B patients with inhibitors.

Authors:  I Warrier; J M Lusher
Journal:  Blood Coagul Fibrinolysis       Date:  1998-03       Impact factor: 1.276
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.